Advertisement

Topics

Yabao Pharmaceuticals Announces Exclusive China Partnership With Lawson Health Research Institute

23:00 EDT 27 Jul 2015 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
BEIJING, July 28, 2015 (GLOBE NEWSWIRE) -- Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351), a leading pharmaceutical company in China, today announced that it entered into an exclusive license with Lawson Health Research Institute (Law...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Yabao Pharmaceuticals Announces Exclusive China Partnership With Lawson Health Research Institute"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Sepsis, septicaemia and blood poisoning
Septicaemia (another name for blood poisoning) refers to a bacterial infection of the blood, whereas sepsis can also be caused by viral or fungal infections.  Sepsis is not just limited to the blood and can affect the whole body, including the organ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...